title: Possible case scenarios and logistic issues in H5N1 pandemic.
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Tsang
authors.forename: Young-Soo
authors.initials: YS
authors.lastname: Shim
authors.forename: Thomas K S
authors.initials: TK
authors.lastname: Wong
authors.forename: C K
authors.initials: CK
authors.lastname: Liam
authors.forename: Philip
authors.initials: P
authors.lastname: Eng
authors.forename: W K
authors.initials: WK
authors.lastname: Lam
authors.forename: W H
authors.initials: WH
authors.lastname: Seto
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology*; D053139:Oseltamivir / Q000627:therapeutic use; D045169:Severe Acute Respiratory Syndrome / Q000517:prevention & control; D053243:Zanamivir / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir; D053243:Zanamivir